Money-Back Guarantee: If your items arrive damaged or become defective within 180 days of normal usage, we will gladly issue a replacement or refund
The critical limitation of natural GLP-1 is its half-life: roughly 23 minutes
Disclosures: Xiaoyang Yang: Nothing to Disclose, Dengqiang Chen: Nothing to Disclose, Zhaoqian Wang: Nothing to Disclose, Yuanyong Wang: Nothing to Disclose, Min Liao: Nothing to Disclose, Jiao Wang: Nothing to Disclose, Feng Lin: Nothing to Disclose, Biao Wu: Nothing to Disclose 544 VALIDATION OF AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA RISK AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C Yu Rim Lee 1 Hyun Young Woo 2 Young Oh Kweon 3 Won Young Tak 4 Se Young Jang 3 Jung Gil Park 5 Min Kyu Kang 5 Jeong Eun Song 6 Jeong Heo 2 Jeong Hwa Lee 7 Min Hwa Park 3 Hyunyeol Lee 8 Soo Young Park 3 , 1 Kyungpook National University, Kyungpook National University, 2 Pusan National University and Medical Research Institute, Pusan National University Hospital, 3 Kyungpook National University, Kyungpook National University Hospital, 4 College of Medicine, Kyungpook National University, 5 Yeungnam University College of Medicine, 6 Daegu Catholic University School of Medicine, 7 Kyungpook National University, Kyungpook National University Chilgok Hospital, 8 School of Electronics Engineering, Kyungpook National University Background: Hepatocellular carcinoma (HCC) can still occur after achieving a sustained virologic response (SVR) to direct-acting antiviral (DAA) therapy in patients with hepatitis C
Suspected adverse reactions should be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
